Publications by authors named "Michi Tanaka"

Claim this Profile
S
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.
Hayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, Koichi Amano, Jun Kikuchi, Michi Tanaka

Mod Rheumatol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
Masayoshi Harigai, Toshihiro Nanki, Ryuji Koike, Michi Tanaka, Kaori Watanabe-Imai

Mod Rheumatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.
Michi Tanaka, Ryoko Sakai, Ryuji Koike, Masayoshi Harigai

J Rheumatol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
Michi Tanaka, Ryuji Koike, Ryoko Sakai, Kazuyoshi Saito, Shintaro Hirata

Mod Rheumatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study.
Hayato Yamazaki, Ryoko Sakai, Ryuji Koike, Yasunari Miyazaki, Michi Tanaka, Yoshiya Tanaka

J Rheumatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.
Ryoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, Kaori Watanabe, Hayato Yamazaki, Michi Tanaka, Yoshiya Tanaka

Arthritis Res Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG.
Natsuka Umezawa, Hitoshi Kohsaka, Toshihiro Nanki, Kaori Watanabe, Michi Tanaka

Mod Rheumatol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
Kaori Watanabe, Ryoko Sakai, Ryuji Koike, Fumikazu Sakai, Haruhito Sugiyama, Michi Tanaka, Yoshiya Tanaka

Mod Rheumatol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
Michi Tanaka, Ryoko Sakai, Ryuji Koike, Yukiko Komano, Toshihiro Nanki, Yoshiya Tanaka

Mod Rheumatol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.
Ryoko Sakai, Michi Tanaka, Toshihiro Nanki, Kaori Watanabe, Hayato Yamazaki, Yoshiya Tanaka

Ann Rheum Dis· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
Michi Tanaka, Ryoko Sakai, Ryuji Koike, Yukiko Komano, Toshihiro Nanki, Yoshiya Tanaka

Mod Rheumatol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis.
Ryoko Sakai, Yukiko Komano, Michi Tanaka, Toshihiro Nanki, Ryuji Koike, Yoshiya Tanaka

Arthritis Care Res (Hoboken)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus-induced pulmonary injury in rheumatoid arthritis patients.
Ryuji Koike, Michi Tanaka, Yukiko Komano, Fumikazu Sakai, Haruhito Sugiyama

Pulm Pharmacol Ther· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis.
Ryoko Sakai, Yukiko Komano, Michi Tanaka, Toshihiro Nanki, Ryuji Koike, Yoshiya Tanaka

Mod Rheumatol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prominent splenic microcalcifications in a patient with systemic lupus erythematosus complicated by antiphospholipid syndrome.
Yoshinori Nonomura, Yoshishige Miyabe, Michi Tanaka, Rieko Tsubata, Toshihiro Nanki

J Clin Rheumatol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.
Yukiko Komano, Michi Tanaka, Toshihiro Nanki, Ryuji Koike, Ryoko Sakai, Yoshiya Tanaka

J Rheumatol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin.
Yasuhiro Katsumata, Masayoshi Harigai, Yasushi Kawaguchi, Chikako Fukasawa, Makoto Soejima, Michi Tanaka

J Rheumatol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Manabu Kawamoto, Masayoshi Harigai, Masako Hara, Yasushi Kawaguchi, Katsunari Tezuka, Michi Tanaka

Arthritis Res Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Momordica charantia constituents and antidiabetic screening of the isolated major compounds.
Liva Harinantenaina, Michi Tanaka, Shigeru Takaoka, Munehiro Oda, Orie Mogami

Chem Pharm Bull (Tokyo)· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Masayoshi Harigai, Masako Hara, Manabu Kawamoto, Yasushi Kawaguchi, Tomoko Sugiura, Michi Tanaka

Arthritis Rheum· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan.
Katsuhiko Inagaki, Tamio Suzuki, Hiroshi Shimizu, Norihisa Ishii, Yoshinori Umezawa, Michi Tanaka

Am J Hum Genet· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membranoproliferative glomerulonephritis and leukocytoclastic vasculitis without cryoglobulin in chronic hepatitis C virus infection.
Ayako Nakajima, Masayuki Adachi, Michi Tanaka, Akira Suwa, Yoshihiro Yasuki

Intern Med· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Two cases of Hansen's disease].
Eiko Ichikawa, Fujio Otsuka, Noriko Horii, Michi Tanaka, Norihisa Ishii

Nihon Hansenbyo Gakkai Zasshi· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
Yasushi Kawaguchi, Masayoshi Harigai, Masako Hara, Chikako Fukasawa, Kae Takagi, Michi Tanaka, Eiichi Tanaka

J Rheumatol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased IL-15 production of muscle cells in polymyositis and dermatomyositis.
Tomoko Sugiura, Masayoshi Harigai, Yasushi Kawaguchi, Kae Takagi, Chikako Fukasawa, Michi Tanaka

Int Immunol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis